Cardiovascular function in nonclinical drug safety assessment: current issues and opportunities
{{output}}
There are several recent examples where clinically significant, safety-related, drug effects on hemodynamics or cardiac function were not apparent until large clinical trials were completed or the drugs entered the consumer market. Such late-stage safety issue... ...